Smith Asset Management Group »

Tg Therapeutics shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2021-06-30 $5.0k 120 41.67
2021-03-31 $6.0k 120 50.00
2020-12-31 $183k 3.5k 52.14
2020-09-30 $94k 3.5k 26.70
2014-06-30 $770k 82k 9.39
2014-03-31 $1.3M 195k 6.90
2013-12-31 $767k 197k 3.90

More positions owned by Smith Asset Management Group

Apple Common Stock - Long (AAPL)
Microsoft Corp Common Stock - Long (MSFT)
Amazon.com Common Stock - Long (AMZN)
Facebook Common Stock - Long (META)
Alphabet Common Stock - Long (GOOGL)
Nvidia Corp Common Stock - Long (NVDA)
Fortinet Common Stock - Long (FTNT)
Adobe Common Stock - Long (ADBE)
United Parcel Service Common Stock - Long (UPS)
Jpmorgan Chase & Co Common Stock - Long (JPM)
Parker-Hannifin Corp Common Stock - Long (PH)
Target Corp Common Stock - Long (TGT)
Capital One Financial Corp Common Stock - Long (COF)
Paypal Holdings Common Stock - Long (PYPL)
Epam Systems Common Stock - Long (EPAM)

View all positions for Smith Asset Management Group

Top funds holding Tg Therapeutics

Vanguard Group
BlackRock
Darwin Global Management
Millennium Management
Wellington Management Company
Susquehanna International
Opaleye Management
Paradigm Biocapital Advisors
683 Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management
Norges Bank Investment Management
Marshall Wace
Gts Securities

View all funds holding Tg Therapeutics